IRADIMED CORP (IRMD)
US46266A1097 - Common Stock
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first...
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference...
iRadimed (IRMD) Shares Cross Above 200 DMA
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP...
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth...
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
A Relative Strength Rating upgrade for Bruker stock shows improving technical performance. Will it continue?
Commit To Purchase iRadimed At $29.52, Earn 3.9% Annualized Using Options
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference...
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the
iRadimed (IRMD) Shares Cross Above 200 DMA
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
iRadimed (IRMD) Shares Cross Above 200 DMA
(NASDAQ:IRMD)
iRadimed Corporation (IRMD) reported strong financial results for Q3 2023, including a 23% increase in revenue and a 43% increase in operating income.
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating...
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
Commit To Purchase iRadimed Corp At $35, Earn 16.6% Annualized Using Options
iRadimed is Now Oversold (IRMD)
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be...
iRadimed Non-GAAP EPS of $0.36 beats by $0.06, revenue of $16.13M beats by $0.47M (NASDAQ:IRMD)
iRadimed press release (IRMD): Q2 Non-GAAP EPS of $0.36 beats by $0.06.Revenue of $16.13M (+26.8% Y/Y) beats by $0.47M.For the third quarter of 2023, the Company expects to...
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
Reports record revenue of $16.1 million for the second quarter of 2023GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36Operating income was $5.0...
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
WINTER SPRINGS, Fla., July 27, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second...